MoneyWorks4Me

Concord Biotech informs about investor presentation

09 Feb 2024 Evaluate
Pursuant to Regulation 30 of Schedule III Part A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Concord Biotech has informed that investor’s presentation on Financial Results for the Third quarter and Nine months ended December 31, 2023 is enclosed.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..